| K-number | K233605 |
| Device name | ADVIA Centaur EBV-EBNA IgG |
| Applicant | Biokit, S.A. |
| Product code | LLM |
| Device class | Class I |
| Decision date | Aug 7, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 866.3235 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov